SenesTech, a leader in rodent birth control solutions, will participate in the Lytham Partners Fall 2026 Investor Conference virtually on September 29-30, 2026. The company will host a webcast presentation and one-on-one investor meetings to discuss its sustainable rodent population management products. This event offers investors a chance to learn about SenesTech's patented Evolve® and ContraPest® brands and their role in pest control. The webcast will be available live and for replay after the event.
SenesTech's upcoming participation in the Lytham Partners Fall 2026 Investor Conference is noted here with Pluang's Consumer Staples sector data as context. Of 46 priced US stocks in this sector on Pluang, 22 rose and 24 fell as of September 18, 2026, 03:42 WIB. Notable movers include Funko Inc (FNKO) at USD 5.38 with a 2.38% increase and 100% sell order activity, and Lamb Weston Holdings Inc (LW) at USD 46.44 with a 2.29% decrease and 100% buy order activity.
Jefferies maintained a Hold rating on Kinder Morgan, lowering its price target from $35 to $33, which remains above the current stock price of $31.31. The company benefits from stable cash flows, with 96% secured by fee-based or hedged contracts, inc...
Several stocks saw sharp gains driven by key company developments. bioAffinity Technologies surged 63.55% after securing a Hong Kong patent for its lung cancer diagnostic technology, boosting its Asian market position. Antelope Enterprise Holdings ro...
KB Home is set to report its Q3 2026 earnings on September 22, with analysts projecting a 45.3% drop in earnings per share to around $0.89 and a 20.2% decline in revenue to about $1.30 billion compared to last year. The consensus EPS estimate has rec...
An investment of $10,000 in Nebius when it resumed trading in 2024 has grown significantly to approximately $105,000 by 2026. This remarkable increase highlights Nebius's strong market performance over the two-year period. Investors who bought in at ...
W.P. Carey expects to invest over $1.9 billion in 2026, reflecting robust growth in its net lease property portfolio. Despite a slight reduction in its price target by Scotiabank to $76, the stock still shows potential upside from current levels. The...
